{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "1310"
          },
          "Protein Change": {
            "ref": "W",
            "alt": "X",
            "position": "437"
          },
          "Description in input context": "homozygous W437X nonsense mutation in the PINK1 gene"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinsonism, Early-Onset",
    "MONDO": "MONDO:0012345"
  },
  "Experiment Method": [
    {
      "Assay Method": "Mitochondrial Respiration Assay",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient-derived fibroblasts",
        "Description": "Mitochondrial respiratory function was analyzed in fibroblasts from a patient with early-onset Parkinsonism compared to normal fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.1310G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Nonsense mutation (premature stop codon)",
          "Result Description": "Reduced mitochondrial respiratory activity and decreased respiratory control ratio in patient fibroblasts."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Normal fibroblasts were used as a control group."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Patient-derived fibroblasts were compared to normal fibroblasts."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Respiratory control ratio > 2.0 and mitochondrial respiratory activity within 95% of control values",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Respiratory control ratio < 1.5 and mitochondrial respiratory activity < 70% of control values",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western Blot for Cytochrome c",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient-derived fibroblasts",
        "Description": "Cytochrome c levels were quantified in patient and normal fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.1310G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss of cytochrome c protein stability",
          "Result Description": "Reduced cytochrome c levels in patient fibroblasts compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Normal fibroblasts were used as a control group."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Patient-derived fibroblasts were compared to normal fibroblasts."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cytochrome c expression within 90-110% of control values",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cytochrome c expression < 80% of control values",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Reactive Oxygen Species (ROS) Measurement",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient-derived fibroblasts",
        "Description": "ROS levels were quantified in patient and normal fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.1310G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased oxidative stress",
          "Result Description": "Elevated ROS production in patient fibroblasts compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Normal fibroblasts were used as a control group."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Patient-derived fibroblasts were compared to normal fibroblasts."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "ROS levels within 95-105% of control values",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "ROS levels > 120% of control values",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}